Overview
Jenny Chen, Ph.D. counsels both US and international clients in a wide-array of patent-related matters in the life science space, including prosecution, opinion, due diligence, licensing and post-grant proceedings. Her practice focuses on matters including antibodies, cell therapies, gene therapies, small molecule therapeutics, diagnosis and pharmaceutical formulations.
She is particularly experienced in strategic counseling on life cycle management of both biological and small molecule products.
Jenny leverages an in-depth understanding of the industries in which clients work. She has prior experience as a postdoctoral fellow in the laboratory of Dr. David Hafler at Brigham & Women’s Hospital, Harvard Medical School. Her research focused on T cell activity in autoimmune diseases such as Type I diabetes.
Results
- Built world-wide patent portfolios covering an antibody product, which obtained marketing approval in various countries*
- Conducted clearance analysis in connection with clients’ generic and biosimilar drug development*
- Conducted due diligence studies on patent landscape and market exclusivity in connection with biotech transaction*
- Assisted leading academic institution in securing patent protection for diagnostic test expected to be used on millions of patients in determining risks for adverse drug reactions*
- Successfully demonstrated continuous diligence for an 11-month period in an interference proceeding*
*Matter handled prior to joining McDermott
Recognitions
- The Best Lawyers in America, Patent Law, 2021
- Massachusetts Super Lawyers Rising Star, Intellectual Property
- IAM Patent 1000, Recommended for Prosecution
Community
- American Bar Association
- American Intellectual Property Law Association
- Boston Patent Law Association
Credentials
Education
Northeastern University School of Law, Boston, J.D., 2006
Baylor College of Medicine, Ph.D., Pharmacology, 2000
Fudan University, B.S., Biochemistry, 1992
Courts/Agencies
United States Trademark & Patent Office
Admissions
Massachusetts
